v3.26.1
SCHEDULE OF ALLOCATION OF FAIR VALUE IN PRIVATE PLACEMENT (Details) - USD ($)
 12 Months Ended
Jan. 01, 2026
Dec. 31, 2025
Dec. 31, 2024
Dec. 19, 2025
 [1],[2]
Nov. 13, 2025
 [1],[2]
Oct. 30, 2025
 [2]
Jun. 27, 2024
 [2]
Apr. 22, 2024
 [2]
Apr. 15, 2024
 [2]
Jan. 17, 2024
 [2]
Subsidiary, Sale of Stock [Line Items]                    
Allocation of proceeds common stock   $ 438,986 $ 63,000              
Share price   $ 0.0758                
Allocation of proceeds warrants   $ 292,230              
Warrants exercise price   $ 0.12                
Private Placement [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Fair value of common stock   $ 1,366,246                
Fair value of common stock percenatge   59.28%                
Allocation of proceeds common stock   $ 425,370                
Share price   $ 0.0256   $ 0.030 $ 0.025 $ 0.060 $ 0.094 $ 0.128 $ 0.104 $ 0.135
Fair value of warrants   $ 938,613                
Fair value of warrants percenatge   40.72%                
Allocation of proceeds warrants   $ 292,230                
Warrants exercise price   $ 0.0190                
Standalone fair value   $ 2,304,861                
Percenatge of total fair value   100.00%                
Allocation of proceeds other equity   $ 717,600                
Private Placement [Member] | Subsequent Event [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Fair value of common stock $ 283,381                  
Fair value of common stock percenatge 60.45%                  
Allocation of proceeds common stock $ 145,701                  
Share price $ 0.0309                  
Fair value of warrants $ 185,430                  
Fair value of warrants percenatge 39.55%                  
Allocation of proceeds warrants $ 95,339                  
Warrants exercise price $ 0.0218                  
Standalone fair value $ 468,811                  
Percenatge of total fair value 100.00%                  
Allocation of proceeds other equity $ 241,040                  
[1] See further Note 11
[2] The Company claims an exemption from the registration requirements of the Securities Act for the private placement of these securities pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated under the Securities Act.